• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).慢性肾脏病患者的血压成分与终末期肾病:肾脏早期评估项目(KEEP)
Arch Intern Med. 2012 Jan 9;172(1):41-7. doi: 10.1001/archinternmed.2011.619.
2
Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study.血压与 CKD 进展的关联:来自 KNOW-CKD 研究的结果。
Am J Kidney Dis. 2021 Aug;78(2):236-245. doi: 10.1053/j.ajkd.2020.12.013. Epub 2021 Jan 11.
3
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.血压指标与慢性肾脏病成人的终末期肾病风险。
Am J Hypertens. 2012 Jul;25(7):789-96. doi: 10.1038/ajh.2012.48. Epub 2012 May 10.
4
Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease.慢性肾脏病中血压成分与终末期肾病及死亡风险
Clin J Am Soc Nephrol. 2009 Apr;4(4):830-7. doi: 10.2215/CJN.06201208. Epub 2009 Apr 1.
5
Age and Outcomes Associated with BP in Patients with Incident CKD.初发慢性肾脏病患者的年龄及与血压相关的预后
Clin J Am Soc Nephrol. 2016 May 6;11(5):821-831. doi: 10.2215/CJN.08660815. Epub 2016 Apr 21.
6
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.血压水平对糖尿病肾病进展的影响:RENAAL研究结果
Arch Intern Med. 2003 Jul 14;163(13):1555-65. doi: 10.1001/archinte.163.13.1555.
7
Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study.时间更新的收缩压与慢性肾脏病进展:一项队列研究
Ann Intern Med. 2015 Feb 17;162(4):258-65. doi: 10.7326/M14-0488.
8
Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP).有和无白蛋白尿的估算肾小球滤过率正常个体发生 ESRD 的风险因素:来自肾脏早期评估计划(KEEP)的结果。
Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S4-11. doi: 10.1053/j.ajkd.2012.12.016.
9
Pulse Pressure and the Risk of End-Stage Renal Disease Among Chinese Adults in Singapore: The Singapore Chinese Health Study.脉压与新加坡华人成年人终末期肾病风险:新加坡华人健康研究。
J Am Heart Assoc. 2019 Dec 3;8(23):e013282. doi: 10.1161/JAHA.119.013282. Epub 2019 Nov 26.
10
Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study.在超过十年的随访期间,伊朗慢性肾脏病成年患者的血压成分与心血管疾病和死亡事件的关系:一项前瞻性队列研究。
J Transl Med. 2018 Aug 15;16(1):230. doi: 10.1186/s12967-018-1603-7.

引用本文的文献

1
Evaluating blood pressure targets in chronic kidney disease: a systematic review and meta-analysis.评估慢性肾脏病的血压目标:一项系统评价与荟萃分析
Hypertens Res. 2025 Jun 20. doi: 10.1038/s41440-025-02262-4.
2
Blood pressure levels and risk of end-stage renal disease in patients with type 2 diabetes who underwent percutaneous coronary intervention: a nationwide population-based study.接受经皮冠状动脉介入治疗的2型糖尿病患者的血压水平与终末期肾病风险:一项基于全国人口的研究。
Sci Rep. 2025 Mar 6;15(1):7832. doi: 10.1038/s41598-025-91835-x.
3
The relationship between kidney function and cardiometabolic risk factors, anthropometric indices, and dietary inflammatory index in the Iranian general population: a cross-sectional study.伊朗普通人群中肾功能与心脏代谢危险因素、人体测量指标和饮食炎症指数之间的关系:一项横断面研究。
BMC Nephrol. 2025 Jan 3;26(1):5. doi: 10.1186/s12882-024-03930-2.
4
Blood Pressure Control and its Determinants among Patients with Chronic Kidney Disease in a Nigerian Tertiary Hospital: A Cross-Sectional Study.尼日利亚一家三级医院慢性肾脏病患者的血压控制及其影响因素:一项横断面研究
Niger Med J. 2023 Feb 24;63(5):394-401. eCollection 2022 Sep-Oct.
5
Isolated Diastolic Hypertension and Kidney and Cardiovascular Outcomes in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.慢性肾脏病中单纯舒张期高血压与肾脏及心血管结局:慢性肾功能不全队列(CRIC)研究
Kidney Med. 2023 Sep 22;5(12):100728. doi: 10.1016/j.xkme.2023.100728. eCollection 2023 Dec.
6
Effects of renal denervation on kidney function in patients with chronic kidney disease: a systematic review and meta-analysis.肾去神经术对慢性肾脏病患者肾功能的影响:系统评价和荟萃分析。
J Hum Hypertens. 2024 Jan;38(1):29-44. doi: 10.1038/s41371-023-00857-3. Epub 2023 Sep 4.
7
Describing Natural History and Exploring Risk Factors for Kidney Function Decline in Persons With CKD of Uncertain Etiology in Sri Lanka.描述斯里兰卡病因不明的慢性肾脏病患者的肾功能下降自然史并探索相关风险因素。
Kidney Int Rep. 2023 Apr 21;8(7):1430-1438. doi: 10.1016/j.ekir.2023.04.010. eCollection 2023 Jul.
8
[Diabetic kidney disease (update 2023) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology].[糖尿病肾病(2023年更新):奥地利糖尿病协会和奥地利肾脏病学会立场文件]
Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):182-194. doi: 10.1007/s00508-022-02147-3. Epub 2023 Apr 20.
9
Hypothetical intervention of targeted systolic blood pressure control of < 120 mmHg on renal prognosis for persons with stage 3-4 chronic kidney disease: an application of parametric g-formula using health checkup data in Japan.假设对 3-4 期慢性肾脏病患者的收缩压目标值控制在 < 120mmHg:应用日本体检数据的参数 g 公式对肾脏预后的干预。
Clin Exp Nephrol. 2023 Jun;27(6):542-547. doi: 10.1007/s10157-023-02341-1. Epub 2023 Mar 22.
10
Blood Pressure Control in Elderly Chronic Kidney Disease Patients.老年慢性肾脏病患者的血压控制
Electrolyte Blood Press. 2022 Dec;20(2):57-63. doi: 10.5049/EBP.2022.20.2.57. Epub 2022 Dec 30.

本文引用的文献

1
Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier.系统评价:慢性肾脏病和蛋白尿中的血压目标作为效应修饰剂。
Ann Intern Med. 2011 Apr 19;154(8):541-8. doi: 10.7326/0003-4819-154-8-201104190-00335. Epub 2011 Mar 14.
2
Intensive blood-pressure control in hypertensive chronic kidney disease.高血压性慢性肾脏病的强化血压控制。
N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975.
3
Aortic PWV in chronic kidney disease: a CRIC ancillary study.慢性肾脏病患者的主动脉脉搏波速度:CRIC 辅助研究。
Am J Hypertens. 2010 Mar;23(3):282-9. doi: 10.1038/ajh.2009.240. Epub 2009 Dec 17.
4
A new equation to estimate glomerular filtration rate.一种估算肾小球滤过率的新公式。
Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006.
5
Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease.慢性肾脏病中血压成分与终末期肾病及死亡风险
Clin J Am Soc Nephrol. 2009 Apr;4(4):830-7. doi: 10.2215/CJN.06201208. Epub 2009 Apr 1.
6
Risk factors for end-stage renal disease: 25-year follow-up.终末期肾病的危险因素:25年随访
Arch Intern Med. 2009 Feb 23;169(4):342-50. doi: 10.1001/archinternmed.2008.605.
7
Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study.单一与联合血压成分与心血管疾病风险:弗雷明汉心脏研究
Circulation. 2009 Jan 20;119(2):243-50. doi: 10.1161/CIRCULATIONAHA.108.797936. Epub 2008 Dec 31.
8
The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population.肾脏早期评估项目(KEEP):项目设计及人群的人口统计学特征
Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S3-12. doi: 10.1053/j.ajkd.2007.12.022.
9
Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).慢性肾脏病患者高血压控制中的种族和性别差异:肾脏早期评估项目(KEEP)的结果
Am J Kidney Dis. 2008 Feb;51(2):192-8. doi: 10.1053/j.ajkd.2007.09.023.
10
A comparative evaluation of various methods for microalbuminuria screening.多种微量白蛋白尿筛查方法的比较评估
Am J Nephrol. 2008;28(2):324-9. doi: 10.1159/000111825. Epub 2007 Nov 29.

慢性肾脏病患者的血压成分与终末期肾病:肾脏早期评估项目(KEEP)

Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).

作者信息

Peralta Carmen A, Norris Keith C, Li Suying, Chang Tara I, Tamura Manjula K, Jolly Stacey E, Bakris George, McCullough Peter A, Shlipak Michael

机构信息

Department of Medicine, San Francisco VA Medical Center, San Francisco, California, USA.

出版信息

Arch Intern Med. 2012 Jan 9;172(1):41-7. doi: 10.1001/archinternmed.2011.619.

DOI:10.1001/archinternmed.2011.619
PMID:22232147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3417125/
Abstract

BACKGROUND

Treatment of hypertension is difficult in chronic kidney disease (CKD), and blood pressure goals remain controversial. The association between each blood pressure component and end-stage renal disease (ESRD) risk is less well known.

METHODS

We studied associations of systolic and diastolic blood pressure (SBP and DBP, respectively) and pulse pressure (PP) with ESRD risk among 16,129 Kidney Early Evaluation Program (KEEP) participants with an estimated glomerular filtration rate of 60 mL/min/1.73 m(2) using Cox proportional hazards. We estimated the prevalence and characteristics associated with uncontrolled hypertension (SBP ≥ 150 or DBP ≥ 90 mm Hg).

RESULTS

The mean (SD) age of participants was 69 (12) years; 25% were black, 6% were Hispanic, and 43% had diabetes mellitus. Over 2.87 years, there were 320 ESRD events. Higher SBP was associated with higher ESRD risk, starting at SBP of 140 mm Hg or higher. After sex and age adjustment, compared with SBP lower than 130 mm Hg, hazard ratios (HRs) were 1.08 (95% CI, 0.74-1.59) for SBP of 130 to 139 mm Hg, 1.72 (95% CI, 1.21-2.45) for SBP of 140 to 149 mm Hg, and 3.36 (95% CI, 2.51-4.49) for SBP of 150 mm Hg or greater. After full adjustment, HRs for ESRD were 1.27 (95% CI, 0.88-1.83) for SBP of 140 to 149 mm Hg and 1.36 (95% CI, 1.02-1.85) for SBP of 150 mm Hg or higher. Persons with DBP of 90 mm Hg or higher were at higher risk for ESRD compared with persons with DBP of 60 to 74 mm Hg (HR, 1.81; 95% CI, 1.33-2.45). Higher PP was also associated with higher ESRD risk (HR, 1.44 [95% CI, 1.00-2.07] for PP ≥ 80 mm Hg compared with PP < 50 mm Hg). Adjustment for SBP attenuated this association. More than 33% of participants had uncontrolled hypertension (SBP ≥ 150 mm Hg or DBP ≥ 90 mm Hg), mostly due to isolated systolic hypertension (54%).

CONCLUSIONS

In this large, diverse, community-based sample, we found that high SBP seemed to account for most of the risk of progression to ESRD. This risk started at SBP of 140 mm Hg rather than the currently recommended goal of less than 130 mm Hg, and it was highest among those with SBP of at least 150 mm Hg. Treatment strategies that preferentially lower SBP may be required to improve BP control in CKD.

摘要

背景

慢性肾脏病(CKD)患者的高血压治疗颇具难度,血压控制目标仍存在争议。各血压组分与终末期肾病(ESRD)风险之间的关联尚不明确。

方法

我们采用Cox比例风险模型,研究了16129名肾脏早期评估项目(KEEP)参与者的收缩压和舒张压(分别为SBP和DBP)以及脉压(PP)与ESRD风险之间的关联,这些参与者的估算肾小球滤过率为60 mL/min/1.73 m²。我们估算了与未控制高血压(SBP≥150或DBP≥90 mmHg)相关的患病率及特征。

结果

参与者的平均(标准差)年龄为69(12)岁;25%为黑人,6%为西班牙裔,43%患有糖尿病。在2.87年的随访期间,发生了320例ESRD事件。较高的SBP与较高的ESRD风险相关,SBP从140 mmHg及以上开始呈现这种关联。在对性别和年龄进行调整后,与SBP低于130 mmHg相比,SBP为130至139 mmHg时的风险比(HR)为1.08(95%CI,0.74 - 1.59),SBP为140至149 mmHg时的HR为1.72(95%CI,1.21 - 2.45),SBP为150 mmHg及以上时的HR为3.36(95%CI,2.51 - 4.49)。在进行全面调整后,SBP为140至149 mmHg时ESRD的HR为1.27(95%CI,0.88 - 1.83),SBP为150 mmHg及以上时的HR为1.36(95%CI,1.02 - 1.85)。与DBP为60至74 mmHg的人相比,DBP为90 mmHg及以上的人发生ESRD的风险更高(HR,1.81;95%CI,1.33 - 2.45)。较高的PP也与较高的ESRD风险相关(与PP < 50 mmHg相比,PP≥80 mmHg时的HR为1.44 [95%CI,1.00 - 2.07])。对SBP进行调整后减弱了这种关联。超过33%的参与者患有未控制的高血压(SBP≥150 mmHg或DBP≥90 mmHg),主要原因是单纯收缩期高血压(54%)。

结论

在这个大型、多样化的社区样本中,我们发现高SBP似乎是进展为ESRD的主要风险因素。这种风险在SBP达到140 mmHg时就已出现,而非目前推荐的低于130 mmHg的目标值,且在SBP至少为150 mmHg的人群中风险最高。可能需要优先降低SBP的治疗策略来改善CKD患者的血压控制。